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This review  gives  a critical  update  of  the  situation  regarding  alveolar  echinococcosis  (AE)  in  Europe  in
humans,  based  on  existing  publications  and  on  ﬁndings  of  national  and  European  surveillance  systems.
All  sources  point  to an  increase  in  human  cases  of  AE  in the  “historic  endemic  areas”  of  Europe,  namely
Germany,  Switzerland,  Austria  and  France  and to the  emergence  of human  cases  in  countries  where  the
disease  had never  been  recognised  until  the end  of  the  20th  century,  especially  in  central-eastern  and
Baltic  countries.  Both  increase  and  emergence  could  be  only  due  to methodological  biases;  this  point  is
discussed  in  the  review.  One  explanation  may  be  given  by  changes  in the  animal  reservoir  of the  parasite,
Echinococcus  multilocularis  (increase  in the  global  population  of  foxes  in Europe  and  its  urbanisation,  as
well  as a possible  increased  involvement  of  pet  animals  as  deﬁnitive  infectious  hosts).  The  review  also
focuses  onto  2  more  original  approaches:  (1)  how  changes  in therapeutic  attitudes  toward  malignant
and  chronic  inﬂammatory  diseases  may  affect the  epidemiology  of  AE  in  the future  in Europe,  since  a
recent  survey  of  such  cases  in  France  showed  the  emergence  of  AE  in  patients  with  immune  suppression
since  the  beginning  of the 21st  century;  (2)  how  setting  a network  of  referral  centres  in  Europe  based
on  common  studies  on  the  care  management  of patients  might  contribute  to  a better  knowledge  of  AE
re.epidemiology  in  the  futu
. Introduction
It was expected that alveolar echinococcosis (AE), a liver cancer-
ike disease due to the infection by the larval stage of the parasite
chinococcus multilocularis,  would disappear from Europe at the
nd of the 20th century because of (1) major improvement of pub-
ic health sanitation, individual hygiene, and food safety measures;
2) decrease in the European population with occupational risks
elated to agriculture/animal breeding; (3) changes in behaviour
f individuals due to urbanisation and better income. The predic-
ion was proved wrong and the number of patients with AE looks
o be both increasing in European countries where AE had been
ecognised since the middle of the 19th century and emerging
n European countries where AE cases were not diagnosed before
he end of the 20th century (Deplazes, 2006; Romig, 2009). AE is,
evertheless, a rare disease (Kern et al., 2003), and an accurate
∗ Corresponding author. WHO-Collaborating Centre for Prevention and Treatment
f  Human Echinococcosis, Dept. of Parasitology, Region and University Hospital,
oulevard Fleming, 25030 Besanc¸ on, France.
E-mail address: dvuitton@univ-fcomte.fr (D.A. Vuitton).
1 http://cnr-echino-alveolaire-ccoms.univ-fcomte.fr/spip.php?article93.
ttp://dx.doi.org/10.1016/j.vetpar.2015.07.036
304-4017/© 2015 Published by Elsevier B.V.©  2015  Published  by  Elsevier  B.V.
assessment of its incidence and prevalence in European popu-
lations and of its potential changes in the future depends upon
the establishment of a standardised, systematic and prospective
recording of AE cases in humans at the European level. This has not
been achieved yet.
Waiting for uniﬁed European recording data, for the present
review we  performed a PubMed (MEDLINE) search of the liter-
ature on AE epidemiology in Europe from 1850 to the end of
2014 in order to critically evaluate the situation of each coun-
try regarding AE in humans and its trends. The search used the
following keywords: ‘E. multilocularis’,  ‘alveolar (or ‘multilocular’)
echinococcosis’, ‘alveolar (or ‘multilocular’) hydatidosis’, ‘alveolar
(or ‘multilocular’) hydatid disease’, ‘Echinococcus alveolaris’, ‘Alveo-
coccus’ and ‘alveococcosis’ (3 key-words used in Russian literature),
combined with ‘epidemiology’, ‘risk factors’, ‘prevalence’, ‘inci-
dence’, ‘immunosuppression’. In addition, in order to disclose the
ﬁrst reported case of AE and the series of cases published in each
country – before and after 1990 – we combined the previous key-
words with the name of each individual country of Europe. When
the original paper was  either not available or in a language differ-
ent from English, French, Spanish, Italian or German, the abstract
was used if available. Whenever useful, published data were com-
plemented by data published in theses and dissertations in French
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nd German, and in reports/opinions published by the European
ommission (EC)-DG SANCO, European Centre for Disease Control
ECDC), and European Food Safety Authority (EFSA) (retrieved by
eb searches from the respective web sites), in abstracts published
n the Proceedings of the International Symposium ‘Innovation for
he management of echinococcosis’,  Besanc¸ on, France, March 2014
Vuitton et al., 2014), and oral communications at the International
SCCAP Meeting ‘Echinococcosis in Europe’, Vilnius, Lithuania,
ctober 2014 (unpublished Abstract Booklet), and by email request
o those in charge of AE registries/observatories in European
ountries.
. Human AE in Europe: a historical perspective
From phylogenetic and paleo-ecological studies one can specu-
ate that E. multilocularis was introduced in Europe by foxes during
he last Pleistocene period (130,000–10,000 years ago). In the ice
ge, the initial spread of the parasite from Siberia to North America
as certainly permitted by the Beringia land bridge (Nakao et al.,
009). The exact origin of the parasite in the northern hemisphere
emains unknown. However, historically, Europe is no doubt the
radle of AE (Vuitton et al., 2003, 2011). Thanks to the observations
ade by the German and Swiss physicians and scientists Siebold,
uhl, Zeller, Meyer and Virchow, the parasitological status of AE
esions was established and distinction from cystic echinococcosis
as founded when the ﬁrst patients were found in the middle of
he 19th century (Virchow, 1855; Perrin, 1932; Tappe and Frosch,
007). The clear distinction between the 2 species, E. multilocularis
nd E. granulosus, would, however, be conﬁrmed only one century
ater (in Vuitton et al., 2011). AE cases were rapidly recognised in
he German and Swiss Jura, and the German, Austrian and French
lps before the end of 19th century (Posselt, 1906; Auer and Aspöck,
991); as early as 1886, a total of 79 AE cases could be reported
Vierordt, 1886). In 1932, Maurice Perrin, an intern of Besanc¸ on
ospital, reported the 10 autochthonous cases which had formally
een identiﬁed in France, including the ﬁrst case diagnosed in 1890
nd 9 other patients who lived in the endemic area of the east and
ortheastern parts of France (Perrin, 1932). The geographic distri-
ution of AE in central Europe, strictly based on human cases, was
early ﬁxed for more than 100 years (Fig. 1).
In Russia, the ﬁrst AE case was diagnosed in 1879, followed by
any others, in the Moscow area, the Volga region (Kazan), and in
iberia (Tomsk and Irkutsk regions); in 1928, among 642 cases iden-
iﬁed in the world (418 in contiguous areas of Germany, Austria,
rance and Switzerland), 209 Russian cases could be recorded
Posselt, 1928). The ﬁrst cases in Turkey were published in 1939
in Altintas, 2003). The earliest reports of human AE in Poland
ated from the 1950s (Sowiakowski, 1955; Głuszcz and Kalczak,
960). The ﬁrst 3 human Greek cases of AE were published in 1978
Theodoropoulos et al., 1978). But some doubt remained about the
eal nature of the reported disease, because of the sympatric pres-
nce of cystic echinococcosis in both countries. Conﬁrmation of the
enome of E. multilocularis in human liver lesions of Polish patients,
eported in 2003, has now unequivocally conﬁrmed human infec-
ion by E. multilocularis in Poland (Myjak et al., 2003). Similar
onﬁrmation has not been given for Greece.
. AE in humans in Europe in the 20th and 21st centuries:
eal increase or biases?.1. Epidemiological observations
Any claim on the increase, emergence or re-emergence of a dis-
ase must be based on sound data, especially when its incidence issitology 213 (2015) 110–120 111
low, and thus any judgment regarding AE should rely on an active
collection of cases performed in all European countries. This was
effective at the end of the 20th century within the framework of
the European Commission (EC-DGXXIV/SANCO)-funded “EurEchi-
noReg” project. This academically-based study was  a cornerstone
for further epidemiological studies on AE in Europe (Kern et al.,
2003). The period of inclusion began in 1982, after ultrasound and
other modern imaging techniques were introduced, and also after
benzimidazoles were proposed for the treatment of AE. With a
common methodology, scientists involved in this study actively
retrieved AE cases diagnosed in their respective countries, namely
Austria, Belgium, Czech Republic, France, Germany, Greece, Italy,
the Netherlands, Poland, Slovakia, Switzerland and the United King-
dom. The registry included all conﬁrmed new cases from January
1982 to December 2000 as well as cases with a diagnosis from ear-
lier periods, provided the patients were alive in 1982. The total
number of veriﬁed AE cases reported to the registry (i.e. prevalence
of cases in the time period 1982–2000) was  559 [258 males (46.2%);
301 females (53.8%)]; 42.0% were diagnosed in France (235 cases),
23.6% in Germany (132 cases) and 21.1% in Switzerland (118 cases).
Most residences were clustered in deﬁned regions: central France,
French Jura and Savoy, Swiss Jura and northeastern Switzerland,
German Jura and Alps in southern Germany, and Austrian Alps in
western Austria. In addition, a few cases were identiﬁed outside the
historic endemic areas. Fifteen patients had acquired the infection
outside their reporting country (including 7 patients originating
from one of the neighbouring European countries). The new and
most exciting ﬁndings were the 14 autochthonous cases reported
from Poland (diagnosed between 1986 and 2000), the case from
Greece and 3 cases from Belgium, a country where autochthonous
cases had never been reported before (Kern et al., 2003).
In the EurEchinoReg European survey, patients were diagnosed
at a mean age of 52.5 years; the gender ratio was  1:1.2. Risk factors
studied in 210 patients included vocational or part-time farming,
gardening, forestry, or hunting in 61% of patients. Such risk factors,
as well as average age (peak between 50 and 60 years) and gen-
der ratio (between 0.8 and 1.2), have been conﬁrmed in all studies
performed in Europe, including in a German case-control study on
risk factors (Kern et al., 2004) and in the more recent study based
on the French population-based AE Registry: most at-risk popu-
lations lived in rural settings [odds ratio (OR) 66.67 for farmers
and 6.98 for other rural people] or gardened in non-rural settings
(OR 4.30) (Piarroux et al., 2011). Compared to Asia and especially
western China where the highest incidence of AE is observed, the
average age of occurrence is higher in Europe, patients are more
often women in Asia, but the rural origin of patients is similar in
both regions of the world (Vuitton et al., 2003).
Thanks to the EC-DG RESEARCH-funded project “Echino-Risk”
aimed at getting knowledge on animal E. multilocularis infection in
Europe (Romig, 2009), autochthonous emergence of E. multilocu-
laris infection in fox populations was  conﬁrmed in many European
countries and an increased risk for human populations became a
concern (Eckert and Deplazes, 1999, 2004; Deplazes, 2006). Within
this context, several countries of central-eastern and northern
Europe have described their ﬁrst autochthonous AE cases and/or a
marked increase in incident AE cases since the 1990s (Bruzˇinskaite˙
et al., 2007; Nahorski et al., 2013; Antolová et al., 2014). Such ﬁnd-
ings will be described in detail below. However, the discovery of
cases in areas where AE was not diagnosed before the 1990s and
the apparent increase in the number of human AE cases in the his-
torically established ‘endemic areas’ of Europe (Schweiger et al.,
2007) could be due to an absence of diagnosis or misdiagnosis in
the past, or to uneven recording over the years; this raises the issue
of methodological biases that have to be discussed ﬁrst.
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.2. Methodological issues
.2.1. Absence or under-diagnosis?
Epidemiology of zoonoses in humans is inﬂuenced by the con-
act with the infectious agent/animal host, but also by technical
nd social advances. Among the latter, progress in diagnostic tech-
iques is a major issue; population ageing and speciﬁcities in the
ealth system of a country/region may  also play a role.
There was an apparent increase in the number of AE cases in
urope after 1970: 559 in the18 years between 1982 and 2000, i.e.
8 years (Kern et al., 2003) versus less than 1000 reported in more
han one century [calculated from the reports published until 1900
in Perrin, 1932) and the 844 cases published between 1900 and
980 (Fesseler, 1990)]. This rise has been attributed to an increase
n fox infection, related to the increase in intermediate host popu-various European countries.
0s (question marks indicate the year of publication of a ﬁrst report when diagnosis
lations (voles) due to changes in land use after European Union
Common Agriculture Policy (Viel et al., 1999; Vuitton et al., 2003).
However, this rise was  certainly also due to major improvement in
imaging techniques since 1970. Before the 1960s, diagnosis of AE
relied upon surgery or necropsy ﬁndings (in Perrin, 1932; Miguet,
1973). Most identiﬁed AE cases were diagnosed by surgeons: either
very advanced cases with biliary or infectious complications or
cases at any stage found by chance at laparotomy performed for
any other condition. Clinically, signs and symptoms of AE could
easily be misdiagnosed as cirrhosis or liver cancer. In many cases,
due to the absence of appropriate treatment for such diseases at
that time, no speciﬁc diagnosis was established. In addition, access
to care was not always easy for patients from the mountainous rural
areas endemic in the disease. The situation markedly improved in
most European countries after the Second World War. This might
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lso have played a role in the recognition of cases. An increase
n both yearly incidence and the number of asymptomatic cases
t diagnosis between 1972 and 1982 and 1983–1993 in a French
ingle-centre study supports the role of imaging methods in AE
iagnosis thus, in its reported incidence after their introduction in
linical practice (Bresson-Hadni et al., 2000). In the same study,
ass screening using serology generated a peak in incidences of
symptomatic patients in 1988 (Bresson-Hadni et al., 2000). How-
ver, in France the situation remained stable afterwards, until the
iddle of the 2000s (Piarroux et al., 2011), which was also observed
t European level (Kern et al., 2003).
It is often argued that emergence of AE cases after 1990 in
lovakia, Lithuania or Poland could have been due to an emerg-
ng interest in this disease, better imaging diagnosis and speciﬁc
are management which was not undertaken during the Soviet
nion era. These countries indeed previously belonged to a dif-
erent system of social organisation and fully entered the European
etwork of scientiﬁc research at the beginning of the 1990s (Kern
t al., 2003). However, it may  be stressed that this is not the case
or Belgium or the Netherlands where the ‘ﬁrst autochthonous
ases’ were also reported after 1990 only (Delbecque et al., 2002;
ern et al., 2003; van Dommelen et al., 2012). On the other hand,
ince its discovery in Germany in the 1850s, AE has been easily
iagnosed by European surgeons and pathologists. Publications in
erman, French, Russian and several other European languages in
he 20 years since the discovery of the ﬁrst AE case made the dis-
ase known by physicians all over Europe; the numerous reports
t national or regional Academies, or the theses/dissertations on
ases observed in the endemic areas testify that the knowledge
n the disease was well disseminated (in Perrin, 1932; Vuitton
t al., 2011). Before the 1970s Russian literature on AE was  very
rominent (in Miguet, 1973). In addition, before the 1980s sys-
ematic autopsy was common practice among hospitals/pathology
epartments across the Soviet Union and associated countries, as
hown in 1975 for Czechoslovakia (Dobiás, 1975). Thus, the occur-
ence of AE cases until the 1970s, if any in a given country, should
ave easily emerged from surgical and/or necropsy reports. After
970, ultrasound examination of the liver was  widely available
n all western European countries. Long asymptomatic, at its late
tage AE is however, a severe disease which cannot be neglected
y clinicians (Bresson-Hadni et al., 2000; Piarroux et al., 2011).
dvanced AE, with jaundice or clinically palpable hepatomegaly
the main presenting symptoms) would have easily been recog-
ised by abdominal ultrasound which became the key-exam for
he differential diagnosis of jaundice and hepatomegaly (Coodley,
970; Weill et al., 1978) and the diagnosis of AE as early as the
970s (Weill et al., 1975). In 1985, the contribution of ultrasound
nd computed tomography examinations to the diagnosis of AE was
lready published in international journals in English, French and
erman (Mörl, 1982; Claudon et al., 1984; Didier et al., 1985), and
quipment for ultrasonography was available in Eastern European
ountries (e.g. in Kovác, 1984). An increase in the ageing population
ll over Europe could also represent a bias; however, the age range
f patients in the population-based registries has not changed; a
light increase in the age of some patients seems to be counter-
alanced by the younger age of others (French Registry: updated
ata).
.2.2. Geographical clustering of AE cases
Another difﬁculty in the interpretation of epidemiological data
or AE is the geographical clustering of human cases. In the so-called
endemic countries’ of Europe, whenever present in a country, AE
s considered to be a very rare disease with average incidences
f 0.03–0.20/100,000 inhabitants/year, with the highest incidence
ound in Switzerland (0.10–0.18/100,000 and no marked variation
uring a 36-year period, until 1997 when the disease became nositology 213 (2015) 110–120 113
longer ofﬁcially notiﬁable). These ﬁgures, however, do not actually
reﬂect the situation of the population at risk. Far higher incidences,
from 4.7–8.1 cases per 100,000 inhabitants/years, are observed in
areas where humans are directly exposed to E. multilocularis infec-
tion (Kern et al., 2003; Piarroux et al., 2011, 2013). This is why
no prevalence per 100,000 inhabitants for each endemic country
(neither for all endemic countries nor all Europe) was given in the
collaborative paper by Kern et al. (2003). The French study, using
data from a population-based registry (Piarroux et al., 2013) con-
ﬁrmed that the main risk factor to present the disease was  living
in AE-endemic areas (relative risk 78.63): almost all AE patients
lived in 22/96 ‘départements’ in northeastern, eastern and central
France. Kulldorff spatial scan analysis, based on data from the same
Registry collected from 1982 to 2011, disclosed at least 4 levels of
disease clusters (Said-Ali et al., 2013). This kind of detailed study
remains to be done at European level, where such a case-clustering
is a very common and general ﬁnding in all countries. As the dis-
ease clusters in rural areas in very speciﬁc geographical/climatic
entities (generally mid-mountain areas with long cold winters and
high rain-fall) (Piarroux et al., 2013), epidemiological ﬁgures cal-
culated with reference to the country’s population are particularly
irrelevant in those countries with the biggest area and highest num-
ber of inhabitants such as Germany, France or Poland; they are more
reliable in Switzerland, Austria, Lithuania or Latvia. Comparing data
expressed at the country level among the various European states
may  thus, be extremely misleading.
4. Current situation in Europe: typology of countries
regarding human cases of AE
If we consider AE epidemiology and the status of human versus
animal cases of E. multilocularis infection in European countries, in
the past 20 years (period 1995–2015), 4 types of countries may  be
described.
4.1. Type 1: Neither human case nor animal E. multilocularis
infection
The ﬁrst group of European countries includes those where no
autochthonous human cases of AE have ever been published and
where E. multilocularis has never been documented in animals.
Some of them apply speciﬁc pet entry regulations, such as the UK,
Malta, Iceland, Ireland, Finland and mainland Norway (Davidson
and Robertson, 2012). In Norway, the parasite is however, present
in the northern Norwegian Svalbard islands, a focus with Siberian
genetic characteristics of the parasite which thus, appears not
related to the ‘European’ focus of infection (Knapp et al., 2012).
No speciﬁc investigations have ever been conducted in Spain and
Portugal which also, at least theoretically, belong to this type, and
to our knowledge, there are no reports regarding AE in humans
from Bulgaria, Albania, Bosnia-Herzegovina, Kosovo, Croatia, and
Macedonia, countries otherwise endemic for cystic echinococcosis.
4.2. Type 2: No human cases but animal E. multilocularis
infection
The second group of countries includes those where no
autochthonous human cases of AE have ever been published and
where E. multilocularis wild cycle in animals is active. Despite the
presence of an autochthonous E. multilocularis cycle in foxes in
northern Italy (Casulli et al., 2005, 2009) and human cases reported
in the 19th century (in Posselt, 1928), no autochthonous human
case has been reported in Italy for the past 50 years. In Serbia, infec-
tion of the beaver as intermediate host was  reported recently, but
no human cases (Bobic´ et al., 2012; C´irovic´ et al., 2012). No infor-
mation has been available on AE epidemiology in Ukraine after the
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rst human case was published in 1976 (Geller and Railian, 1976),
lthough 36% of red foxes of western Ukraine are infected with the
arasite (Kharchenko et al., 2008); in Belarus, foxes were also found
nfected in Belorussian Polesie, a region at the Ukrainian and Polish
order (Shimalov and Shimalov, 2001). Until now, no human cases
f AE have been formally reported in Sweden and Denmark, after
rst evidence of E. multilocularis infection in foxes was given in 2011
n southwestern Sweden (Osterman Lind et al., 2011; Uhlhorn et al.,
011) and in 2000 and in 2012 in Denmark (Kapel and Saeed, 2000;
nemark et al., 2013). There are so far no conﬁrmed human cases
f AE from Estonia where foxes and raccoon dogs have been found
nfected by E. multilocularis (Moks et al., 2005; Süld et al., 2014).
mong 14 cases of echinococcosis in humans ofﬁcially registered
n Estonia, differentiation between AE and CE was not achieved, and
nly CE cases were published in detail (Marcinkute˙ et al., 2015).
.3. Type 3: Both human AE cases and animal E. multilocularis
nfection in countries considered to be ‘AE-free’ before 1995
The third group of countries includes those where the disease
as unknown in humans before and has been diagnosed occasion-
lly in one or several patients after the end of the 20th century.
ince 1999, human cases have been reported in Slovakia (Antolová
t al., 2009), Slovenia (Logar et al., 2007), Romania (Sikó et al., 2011),
zech Republic (Hozáková-Lukácová et al., 2009) and Hungary
Horváth et al., 2008) (Fig. 1). In most of the ‘newly endemic’
ountries of central-eastern Europe, the number of cases remains
imited (Eckert, 1997; Sréter et al., 2003). These rather low numbers
hould not mask the fact that fox infection rate by E. multilocularis
s fairly high in several areas of these countries. Because of the time
ag between infection and AE diagnosis in humans, human inci-
ence could markedly increase in the next few years, as is already
bserved in Slovakia (Antolová et al., 2014). In this country, the ﬁrst
 cases were observed in 2000, in the Zˇilina Region, in northwest-
rn Slovakia, where 50% of foxes are infected, and 26 clinical cases
ere recorded from 2000 to 2013, most of them from the highly
ndemic areas, with 1/3 under 40 years (Zˇilina and Presˇov, with
8% of foxes infected). A similar trend is also detected for the Czech
epublic, with cases in young patients (Hozáková-Lukácová et al.,
009).
In countries of northwestern Europe, the ﬁrst case of AE in
umans was diagnosed in the Netherlands in 2012 (van Dommelen
t al., 2012). In Belgium where the ﬁrst 3 cases had been diag-
osed between 1996 and 1999 (Kern et al., 2003), 6 additional cases
ere reported between 2000 and 2013 (Detry et al., 2005; Keutgens
t al., 2013; Landen et al., 2013). Although there are no published
uman cases in Sweden and Denmark, personal communication
ith scientists from these countries indicate that investigations
re ongoing to ascertain the autochthonous origin of recently diag-
osed AE patients; if conﬁrmed, this would move these countries
o the ‘Type 3’. In northeastern Europe/Baltic area, where the dis-
ase was either unknown or diagnosed very rarely until the end
f the 20th century, the number of human cases has considerably
ncreased within the decade 2000–2010. Despite a population close
o 3 million inhabitants, Lithuania is now among the top 5 Euro-
ean countries regarding the total number of cases and likely to be
anked ﬁrst for AE incidence at country level (Bruzˇinskaite˙ et al.,
007; Marcinkute˙ et al., 2015). From 1997 to July 2006, 80 AE cases
ere diagnosed at the reference hospitals for AE, in Vilnius, Lithua-
ia; this trend was conﬁrmed for the following years, with 16 more
ases reported in 2007–2008 (Sˇarku¯nas et al., 2010) and a total of
79 cases between 1997 and 2013 (Marcinkute˙ et al., 2015). The
ge of patients averaged 60 (range 21–83), 65.9% were women;
3/179 patients died within the 16-year observation period.  Most
E patients originate from the northwestern and northeastern parts
f Lithuania but cases have been recorded from many parts of thesitology 213 (2015) 110–120
country, which suggests, together with ﬁndings in deﬁnitive and
intermediate animal hosts, that the whole territory of Lithuania
should currently be endemic for AE (Marcinkute˙ et al., 2015). With
a population of 2 million inhabitants, Latvia where 29 AE human
cases have been reported for the 1996–2010 period also belongs to
the newly discovered endemic areas where the disease seems to be
emerging fast (Tulin et al., 2012).
In Poland, a systematic collection of AE cases by a consortium of
Polish referral centres was published in 2013: in 1990–2011 a total
of 121 AE cases (incidence 0.014/100,000/year) were diagnosed in
this country of 38.5 million inhabitants. They included 12 cases
reported to the EurEchinoReg and 27 (22.3%) cases found during
ﬁeld studies in endemic areas screened for human AE (Nahorski
et al., 2013). Once again, very young patients were among the
recorded cases (4 patients from 6 to 11 years old). Aggregation of
9 cases, all of them genetically related, in 4 families was  observed.
AE cases were observed in 12 among 16 provinces in Poland and
were distributed unevenly; the largest number (65 cases, 53.7%)
was recorded in the Varmia and Masuria province and in Pod-
laskie province (11 cases), in northeastern Poland, at the border
of the Russian Kaliningrad enclave and Lithuania. Cases were also
observed in the northwest (Baltic Sea) and west (German border)
regions. As expected, the human case distribution is consistent with
the known prevalence of E. multilocularis-infected foxes and also
raccoon dog infection (Malczewski et al., 2008; Nahorski et al.,
2013). During the last 20 years, a steady increase of AE cases in
Poland was observed with some degree of acceleration after 2005
(Nahorski et al., 2013).
4.4. Type 4: Increase in both human AE cases and animal E.
multilocularis infection in historic endemic areas
Several studies document a recent upward trend in incidence
in historic endemic areas. Changes in AE incidence may be reliably
evaluated only in those countries where the case recording system
has not changed for the past 20 years, i.e. Switzerland, France and
Austria. In Switzerland, a more than twofold increase of the annual
incidence was  reported between the periods 1993–2000 (10–15
cases/year) and 2001–2005 (20–30 cases/year) (Schweiger et al.,
2007) and the incidence stabilised at the highest level of 20–30
cases/year (for 8 million inhabitants) for the following years (Peter
Deplazes, Institute of Parasitology, Zurich, personal communica-
tion). Similar observations have been made since the mid  2000s
in France: the median number of incident cases increased from 14
until 2006 to 28 from 2007 to 2013, with peaks of incidence of 35
in 2009 and 37 in 2012 (for a country of 66 million inhabitants)
(Chauchet et al., 2014; FrancEchino Registry, unpublished updated
data reported to the InVS, ECDC and EFSA). Similar trends have
been pointed out in Austria by the Austrian AE reference centre:
while the median number of incident cases in Austria (8 million
inhabitants) was  2 and 3 cases during 1991–2000 and 2001–2010,
respectively, the registration of 13 new AE patients in 2011 was
unexpected (Schneider et al., 2013). Since then, from 2011 to 2014,
the average incidence stabilised at a median of 9 cases per year,
which is 3 times that observed before (Herbert Auer, Austrian AE
reference centre, unpublished updated data).
In addition, changes in the geographic distribution of the
AE cases in the various historical endemic countries have been
observed. This was  described for France: from the beginning of the
21st century, more cases have been observed in the Ardennes area
(Belgian border) and in the southeastern part of the Massif Cen-
tral (Aveyron) than in the past; and within the highly endemic area
of Franche-Comté, the number of human cases has increased in
the Haute-Saône ‘département’ while before 2000 the cases were
mostly restricted to the Doubs ‘département’ (Piarroux et al., 2013;
Said-Ali et al., 2013; and unpublished, updated data of the French
 Parasitology 213 (2015) 110–120 115
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Fig. 2. Magnetic nuclear resonance imaging T2-weighted images in an immunosup-
pressed patient.
Huge sized-alveolar echinococcosis lesions, with numerous pathognomonic hyper-D.A. Vuitton et al. / Veterinary
E Registry). Similar regional changes have been recently described
or Austria by Austria’s National Reference Centre for Echinococco-
is: data for the past 21 years show a continuous increase of cases
n Vorarlberg which has become the ﬁrst region in terms of AE inci-
ence (7 cases in 2011), although it is the Austrian region with the
owest population (Auer and Aspöck, 1991; Schneider et al., 2013).
. Increased incidence of human AE: increased E.
ultilocularis animal reservoir and/or increased human
usceptibility in European populations?
.1. Changes in E. multilocularis reservoir
The recent unexpected increase in AE incidence may ﬁnd its ori-
in both in an increase and/or geographical extension of the animal
eservoir of the parasite (Romig, 2009; Combes et al., 2012) and/or
n an increase in human susceptibility to parasite infection, since
he occurrence and development of the disease is inﬂuenced by the
mmune status of the host (Koch et al., 2003; Vuitton et al., 2006;
uitton and Gottstein, 2010).
The considerable increase in the fox populations in Europe,
artly due to rabies vaccination but also to changes in lifestyle and
ccupation in rural areas, thus, in the general attitude of the society
owards foxes, has certainly much contributed to the geographic
issemination of infected foxes and thus, to the increase in E. mul-
ilocularis infection pressure in the environment in most European
ountries (Eckert, 1997; Dubinsky et al., 2001, 2006; Schweiger
t al., 2007; Takumi et al., 2008; Berke et al., 2008; Bagrade et al.,
008). Urbanisation of the source of infection is also an important
rend over the last 20 years, with infected foxes present in the
ities of all endemic areas (Hofer et al., 2000; Stieger et al., 2002;
eplazes et al., 2004; Fischer et al., 2005; Romig et al., 2006; Comte
t al., 2013). However, despite remarkable isolated observations,
 real signiﬁcant shift to a more frequent ‘urban’ residence of the
atients has not been evidenced yet by clinicians using sound lon-
itudinal studies from reliable registries in Europe (Piarroux et al.,
011, 2013; Deplazes and Gottstein: personal communication).
Involvement of dogs as deﬁnitive hosts also makes human popu-
ations closer to the infectious sources; such an inﬂuence has been
ell demonstrated in China (Craig et al., 2000; Bartholomot et al.,
002). Dog infection has been shown in countries with rapidly
mergent AE such as Slovakia and Lithuania, highly suggesting a
domestic cycle’ (Antolová et al., 2009; Bruzˇinskaite˙ et al., 2009).
ccasional E. multilocularis infection of pigs in Lithuania could also
upport this hypothesis. Simple calculations in endemic countries
ike Switzerland have stressed the elevated risk of human infec-
ion by pet dogs compared to foxes (Hegglin and Deplazes, 2013).
he discovery of ‘family-clustered cases’, as was shown in France
Piarroux et al., 2011) and in Poland (Nahorski et al., 2013), may
lso support the involvement of dogs in infection, although genetic
actors of susceptibility may  play a role (Eiermann et al., 1998; Yang
t al., 2006). The involvement of cats in the increased infection risk
annot totally be ruled out although worm fertility is not as often
btained in cats as it is in dogs (Kreidl et al., 1998; Petavy et al., 2000;
onaka et al., 2008; Deplazes et al., 2011). Young age of several AE
atients in newly endemic countries, which has been repeatedly
entioned in recent reports and described above, could be an indi-
ator of important infection pressure in the environment, and of
he role of domestic animals in transmission, as was suggested in
hina (Craig et al., 2000; Yang et al., 2008).
.2. The emergence of AE in patients with immunosuppressive
herapyOn the other hand, a signiﬁcant number of AE cases have
een reported for the past 15 years in patients who received
rgan transplantation or were treated for malignant or chronicdense microcysts found in the right and left lobes of the liver in a patient with
therapeutic immune suppression. The patient presented with fatigue and right
quadrant abdominal pain and got abdominal ultrasound examination.
inﬂammatory diseases (Gruener et al., 2008; Kayacan et al., 2008;
Gaultier et al., 2009; Geyer et al., 2011; Weiner et al., 2011; Kern
et al., 2011; Dentan et al., 2012). AE cases in patients with cancer,
malignant haematological disorders, chronic inﬂammatory dis-
eases, transplantation, and AIDS, before or at AE diagnosis, were
extracted from the population-based AE French registry database
(1982–2012) (Chauchet et al., 2014). Fifty patients were found with
such immunosuppression (IS)-associated conditions among 509 AE
cases diagnosed from 1982 to 2012. There was  signiﬁcantly higher
progression in IS/AE than in non-IS/AE case incidence between the
last 2 decades. Acquired therapeutic immunosuppression was the
main factor for AE occurrence and its fast progression (Fig. 2). IS-
associated conditions modiﬁed AE presentation: this and negative
serology made diagnosis more problematic, delayed or erroneous,
and generated wrong therapeutic interventions. As the proportion
of subjects with IS conditions is increasing in Europe, because of
treatment intensiﬁcation in patients with chronic inﬂammatory
diseases and malignant disorders, and the use of biotherapeutic
agents, it is likely that the number of patients with accidental AE-
detection will also increase. All physicians in the endemic areas
should be aware of this new situation which might be even trick-
ier in those countries where AE is currently emergent, because of
the lack of awareness of physicians in general, and the possible
confusion between metastatic and AE images by oncologists at the
follow-up of patients.
6. Public health consequences of the disease and situation
of AE data recording in Europe
In the world, AE has been estimated to cause an annual loss
of approximately 666,000 disability-adjusted life years (DALYs)
(Torgerson et al., 2010). Currently the costs per AE patient in
Europe average D 110,000 (Torgerson et al., 2008, 2010). In the his-
toric endemic areas, patients are more often diagnosed at earlier
stages of the disease than 40 years ago, thanks to the awareness
of physicians (Bresson-Hadni et al., 2000; Piarroux et al., 2011);
however, many patients continue to present at advanced stage of
infection, especially in the ‘emerging’ endemic areas (Bruzˇinskaite˙
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Table  1
Situation of the various European countries regarding the legal notiﬁcation of (alveolar) echinococcosis, according to ‘The European Union Summary Report on Trends and
Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2010’ (ECDC and EFSA, 2012; accessible through: http://www.efsa.europa.eu/en/efsajournal/pub/2597.
htm).
Country Notiﬁable in humans Notiﬁable in animals Notiﬁable in food
Austria Yes, since 2004 Yes, since 1994 Yes, since 1994
Belgiium Yes <1999 V Yes, since 1998 Yes, since 2004
Bulgaria yes – –
Cyprus  Yes, since 1969 – –
Czech  Republic Yes No –
Denmark No Yes –
Estonia Yes, since 1986 Yes, since 2000 Yes, since 2000
Finland 1995 Yes, since 1995a Yes, since 1995a
France Yes V No –
Germany Yes Yes, since 2004 –
Greece  Yes Yes, since 1980 –
Hungary Yes, since 1960 No Yes, since 1984
Ireland Yes, since 2004 – no
Italy  – Yes Yes, since 1964
Latvia Yes, since 1999 Yes Yes
Lithuania Yes, since 1990 Yes –
Luxembourg Yes No
Malta Yes – –
Netherlands No Yes Yes
Poland Yes, since 1959/1997b – –
Portugal Yes Yes –
Romania Yes Yes, since 1942 –
Slovakia Yes yesc No
Slovenia Yes, since 1977 Yes <1991d Yes, since 2003
Spain  Yes, since 1982 Yes, since 1994 Yes, since 1994
Sweden Yes, since 2004 Yes >30 years Yes >30 years
United  Kingdom Yes V Yes, since 1998e No
Iceland – – –
Liechtenstein Yes – –
Norway Yes, since 2003 Yes, since 1985 Yes, since 1965f
Switzerland No Yes, since 1966 –
V: on a voluntary basis (not legally mandatory).
a In Finland, notiﬁable also before 1995, but legislation changed in 1995.
b In Poland, from 1959, registered together with other tapeworms, from 1997, registered separately.
c In Slovakia, only clinical cases.
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cases to the State Epidemiological Sanitary Inspection. Based on
information provided by ﬁve clinical centres the ﬁrst attempt was
made in 1998 to register AE cases within the framework of thed In Slovenia, the year of independence; however, this disease was  notiﬁable befo
e In the United Kingdom, notiﬁable only under the Speciﬁed Animal Pathogens O
f Mandatory meat inspection for hydatid cysts.
t al., 2007; Nahorski et al., 2013). The relatively low number
f patients is largely balanced by the life-long ABZ treatment,
terative hospital stays and major surgical operations including
iver transplantation, which greatly increase the economic cost in
igh-income countries while impairing proper access to care in
esource-constrained countries (Torgerson et al., 2010). Response
o the new epidemiological challenges includes the establishment
f (1) an accurate European Registry of human AE cases, (2) Referral
entres in endemic regions, and (3) a network of health profession-
ls to better manage individual patients, to perform prospective
tudies and to deal with the occurrence of the disease in regions
here it was previously absent.
.1. Status of AE surveillance at the national level in Europe
The Swiss system of AE case recording after mandatory notiﬁ-
ation was cancelled in 1997 currently relies on active retrieval of
ases by 2 academic reference centres, in the Institutes of Para-
itology of Zurich and Bern Medicine and Veterinary Medicine
chools respectively, with the collaboration of the parasitology
epartment of the Swiss Tropical and Public Health Institute, Basel
niversity, and of the clinical departments of university hospitals
n charge of patient care management (Peter Deplazes, personal
ommunication). This academic consortium has published sev-
ral retrospective studies based on the national collection of cases
Ammann et al., 2004; Kadry et al., 2005; Stumpe et al., 2007;
orgerson et al., 2008; Frei et al., 2014).91.
998.
In Germany, legal notiﬁcation was  established in 2001 to allow
AE epidemiological surveillance all over the country (Robert Koch
Institut, 2006). However, when evaluated and compared to other
sources of case recording in Germany, such a formal notiﬁcation
has not proved to be fully efﬁcient. A 3-source capture–recapture
analysis (using proxy matching identiﬁers for detecting double or
triple recording, since the legal notiﬁcation is anonymous) showed
that the national surveillance system failed to detect 67% of AE inci-
dent cases in Germany in the 2003–2005 period (Jorgensen et al.,
2008).
In Austria, human AE case recording for the past 40 years has
mostly relied on academic studies (Auer and Aspöck, 1991; Kreidl
et al., 1998; Kern et al., 2003; Schneider et al., 2013). Since January
1st 2014, all cases diagnosed in Austria have to be reported electron-
ically to the national reference centre where laboratory as well as
clinical information on each patient should be collected (Auer, per-
sonal communication). Since January 2013, a specialised outpatient
clinic has been established in the Dept. of Infectious Diseases of the
University Hospital, in Vienna, where patients may  seek for advice
or treatment, which will improve case recording in the future.1
In Poland, there is currently a legal obligation to report all AE1 http://infektiologie-hygiene.universimed.com/artikel/spezialambulanz-
echinokokkose-%E2%80%93-klinik-diagnose-und-therapie.
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Fig. 3. European Alveolar Echinococcosis (AE) referral centre networking in the past 20 years.
(A)  Published multicentre studies on epidemiology (EurEchinoReg), epidemio-genetics (HLA studies), and care management (liver transplantation and per-endoscopic
interventions) of patients with AE involved in published studies.
Red dots: Kern et al. (2003); purple dots: Eiermann et al. (1998) and Zhang et al. (2003); light blue dots: Koch et al. (2003); dark blue dots: Ambregna et al. (2014), in
preparation; communication at the United European Gastroenterology Week, Vienna, Austria (2014).
(B) European Quality External Evaluation system for AE serology (coordination: WHO-Collaborating Centre for Prevention and Treatment of Human Echinococcosis and
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clusions of scientiﬁc publications on the subject and in the present
Review. This might be partially explained by the fact that therench  National Centre for Alveolar Echinococcosis).
urple stars: participants since the preliminary study (2013); yellow stars: participa
tudy  (2014).
urEchinoReg program (Kern et al., 2003). In 2003 in an effort to
ormalise and extend the registry, the Chief Sanitary Inspectorate
CSI) of Poland was asked to continue the National AE Registry. First
ata recorded by the Polish AE Registry were published in 2013
Nahorski et al., 2013). A similar endeavour has been launched in
ithuania (Marcinkute˙ et al., 2015).
In nearly all other countries, even though AE is a notiﬁable
isease in most of them (Table 1), sound data come mostly from
cademic studies, since notiﬁed cases do not represent the totality
f cases and because the details given for each case are not sufﬁ-
ient to allow research work on risk factors and their changes with
ime and/or to get correlations with animal/environmental data.
So far, to our knowledge a population-based publicly-funded
egistry only exists in France, with a satisfactory level of complete-
ess (Grenouillet et al., 2010; Charbonnier et al., 2014). There is
o legal obligation for the notiﬁcation of AE cases in France but
he quality of AE case recording by the French National Refer-
nce Centre (CNR)2 is evaluated every year by the French National
nstitute for Disease Surveillance (InVS) which ﬁnancially supports
he registry. This French AE Registry was designed on the model
f the WHO-qualiﬁed cancer registries and was  approved by the
egional Committees for the Protection of People (CPP) in medical
esearch and by the National Informatics and Liberty Commission
CNIL) regarding non-anonymous personal data; more than 99% of
atients have agreed to provide such data. Case retrieval is based
n spontaneous notiﬁcation by the physicians of the FrancEchino
etwork, a consortium of professionals in charge of AE case man-
gement in all endemic regions (Fig. 3). This is completed each year,
or the whole French territory including the so-called ‘non-endemic
reas’, by an active research of cases from the parasitology and
2 http://cnr-echino-alveolaire-ccoms.univ-fcomte.fr/spip.php?article91.the ﬁrst French national study (2013); green stars: participants in the ﬁrst European
pathology departments of public hospitals, from 2 medical biology
laboratories which perform nearly 80% of parasite serology exams
in the private sector, and from the public hospital pharmacies, in
charge, legally, of providing albendazole to the patients with AE.
Follow-up of cases is performed every 2 years, to assess mortal-
ity and its relationship with AE. A new database better adapted to
easy data entry by the patients’ physicians, and to the use of the
Registry for scientiﬁc research was  designed in 2014 (Charbonnier
et al., 2014).
6.2. Status of AE surveillance at the European level
The EC has made notiﬁcation of ‘echinococcosis’, both cystic and
alveolar, mandatory for its member states, among other zoonoses,
according to the Directive 2003/99/EC1.3 Data are collected from
the National Institutes of Disease Surveillance or other similar
institutions established by the member states, and they are pub-
lished in the ‘Summary report on Trends and Sources of Zoonoses,
Zoonotic Agents and Food-borne Outbreaks’ co-edited by the ECDC
and the EFSA (ECDC and EFSA, 2012). However, the sources of
epidemiological data and the modalities of data collection and
expression are very diverse and markedly different between the
various member states. The 2010 Summary Report concludes: ‘The
number of human echinococcosis cases decreased slightly in 2010’.
This assessment may  sound amazing if it is compared to the con-EU Summary Report analyses data collected from governmental
3 Directive 2003/99/EC1 of the European Parliament and of the Council of 17
November 2003 on the monitoring of zoonoses and zoonotic agents, amending
Council Decision 90/424/EEC and repealing Council Directive 92/117/EEC. OJ L 325,
12.12.2003, p. 31–40.
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ources without harmonised methodologies, including a frequent
nd regrettable confusion between E. multilocularis and E. granulo-
us. The species was declared “unknown” for 21% of cases. There
as no differentiation between ‘autochthonous’ and ‘imported’
ases, a differentiation which is important for a proper understand-
ng of the epidemiological situation of both cystic and alveolar
chinococcosis, 2 very different diseases in terms of presentation
nd public health signiﬁcance. In 2010, among non-member states,
witzerland and Norway also reported data on zoonoses to the
CDC and EFSA; however, data for echinococcosis were only avail-
ble for Norway, not for Switzerland, the country with the highest
ncidence of AE cases in Europe.
. How to better assess human epidemiology and ﬁght
gainst AE in Europe?
Standardised registration and prospective follow-up protocols
re essential to properly assess the epidemiology of the disease
nd its trends in all European countries. An appropriate surveil-
ance scheme at European level is thus, absolutely necessary to set
p similar case-collection frameworks and procedures in the vari-
us European countries. Such a surveillance scheme should clearly
ifferentiate between E. multilocularis and E. granulosus infection,
nd between autochthonous and imported cases; it should include
ata on a prolonged follow-up of the patients to draw survival
urves. It should also provide environmental data, data on animal
ntermediate and deﬁnitive hosts collected in a uniform manner,
nd analyse all data in a comprehensive way. National initiatives
nd academic attempts at networking clinical centres in univer-
ity hospitals to perform retrospective studies on AE epidemiology
nd/or care management of AE patients (Fig. 3) should pave the way
or a more reliable European AE recording system with commonly
greed standards, provided that appropriate funding is available
Charbonnier et al., 2014). The constitution of a common European
egistry would also make prospective studies on selected cases
ossible to test for diagnosis or follow-up tools and for new thera-
eutic options (Kern, 2006; Vuitton and Bresson-Hadni, 2014).
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